Evidence map›Paper›PMID 40786582›Full record

ArticleCaspian journal of internal medicine2025

Seroepidemiology of

Marzieh Latifi, Habib Rahban, Elahe Pourhosein, Tannaz Hajialireza Tehrani, Parisa Mahjoobi, Sanaz Dehghani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Caspian journal of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marzieh LatifiDepartment of Public Health, School of Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Habib RahbanCreighton University School of Medicine, St. Joseph Hospital and Medical Center, Department of Cardiovascular Disease, Phoenix, Arizona.
Elahe PourhoseinOrgan Procurement Unit, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Tannaz Hajialireza TehraniOrgan Procurement Unit, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Parisa MahjoobiDepartment of Medical Parasitology and Mycology, Medicine, Alborz University of Medical Sciences, Alborz, Iran.
Sanaz DehghaniOrgan Procurement Unit, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Opportunistic infection after transplantation is a serious problem, with Methods: A total of 342 kidney transplant patients participated in this cross-sectional study using the census method after obtaining consent. Data were collected by reviewing medical records and the transplant database, including demographic characteristics and infectious tests related to kidney transplantation. The collected information was entered into SPSS18 software. Results: The age of the subjects ranged from 10 to 73 years, with 125 patients having kidney failure due to ERDS. The rate of exposure to T. gondii in kidney transplant patients was 54.2%. 125 patients experiencing kidney failure due to ERDS. In kidney transplant patients, the exposure rate to Conclusion: Physicians should be aware of preventive measures and should consider early diagnosis in cases of compatible symptoms. Screening for anti-Toxoplasma IgM antibodies in potential donors is recommended.

Identifiers

PMID40786582
PMCPMC12329353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.